Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus.

The research explores the ability of a DNA vaccine – enhanced with single-round infectious particles (SRIPs) – to provide better protection against West Nile virus in mice and to develop virus-neutralizing antibodies in horses. This may open new possibilities for vaccinations against other flaviviruses besides the West Nile virus.

Key Concepts and Processes

• The premise of this study revolves around the development of a DNA vaccine against the West Nile virus. DNA vaccines offer a safer alternative to inactivated or live attenuated viruses since they contain replication-defective viruses. However, they often fail to stimulate a sufficient immune response, thereby reducing their effectiveness.
• The research aimed to augment the protective capability of the DNA vaccine by co-expressing the capsid protein from a separate promoter. This process resulted in two separate entities: secreted virus-like particles and single-round infectious particles (SRIPs).
• The secreted virus-like particles were produced when the capsid-deleted RNA transcript was replicated and translated in transfected cells. These particles do not contain the nucleocapsid (protein shell of the virus) and hence are structurally incomplete.
• In contrast, the SRIPs were created when the capsid protein co-expressed by the virus packaged the RNA. These particles are capable of infecting neighbouring cells.

Main Findings

• Post infection with SRIPs, the cells replicated the RNA again to produce additional virus-like particles. However, due to the absence of capsid RNA, no further SRIPs were formed, and therefore no further spread occurred.
• The modified DNA vaccine offered enhanced protection to mice after lethal West Nile virus infection, as compared to a similar construct that did not encode capsid.
• The DNA vaccine also spurred the development of virus-neutralizing antibodies in horses, representing promising results for larger mammals as well.

Future Implications

• The approach delineated in this study could potentially enable vaccination against other pathogenic flaviviruses, not just West Nile virus. Given the varied nature of flavivirus-caused diseases, this discovery paves the way for an efficient vaccination strategy to tackle a variety of related viruses.